Schain Research
Malin Heyman is a seasoned professional with extensive experience in various leadership roles across the financial and technology sectors. Currently serving as a Founding Partner at Ciencia Technology and Founder of Violexa, Malin also holds positions as a Member of the Board of Directors at Schain Research and Senior Specialist QA Test Engineer at Nasdaq since October 2021. Prior roles include being a Founding Partner and Chairman of the Board at Swimbird AB from November 2018 to November 2021 and over 18 years as the Head of Products at SEB, where responsibilities spanned business development for Prime Brokerage Services and related financial products. Malin's academic background includes studies at Uppsala University.
This person is not in any teams
This person is not in any offices
Schain Research
Schain Research is a research consultancy company specialized in health data sciences and real world evidence to support pharmaceutical companies throughout all phases of drug development. We advance knowledge and contribute to accelerated drug development processes, evidence based healthcare and improved patient outcomes by applying advanced analytics on population-based data sources. Our team has extensive experience from R&D, medical affairs, market access, biostatistics, epidemiology and economics.